With all signs pointing to a busy influenza season, we need to get flu vaccine coverage back to the pre-COVID level, says Dr. Gregg Sylvester, Chief Health Officer of BIO member company, CSL Seqirus.
How serious is this season? Australia saw a significant increase in flu this year, with case numbers similar to their extra-long 2019 season and an especially strong impact among children. The southern hemisphere’s flu season is an indicator for the north.
What happened last year? The 300,000 hospitalizations for flu in the United States in 2022-23 was the highest rate since the 2010-11 flu season. There were as many as 54 million cases and 19,000 deaths.
What should we do? The Centers for Disease Control and Prevention (CDC) recommends flu shots for eligible individuals aged six months and older. The rate of flu vaccination dipped during the pandemic and has not yet recovered.
Why it matters: Flu vaccines “prevented 1.8 million flu-related illnesses, 1,000,000 medical visits, 22,000 hospitalizations, and nearly 1,000 deaths” in 2021-22, according to the CDC.
What they’re saying: “I encourage everyone to speak with their doctor or local pharmacists about getting a flu vaccine early, before flu season reaches its peak” in December-March, says Sylvester.
Read the Bio.News interview.
Find out more at Flu.com.
More Health Care News:
Life Science Leader: Biotech Veteran Pushes New Science And Regulatory Change
“(Ashvattha CEO Jeff) Cleland is irked by the Inflation Reduction Act’s (IRA) divergent timelines for negotiating the prices of top-selling small molecules versus large molecules sold through Medicare. For one thing, Ashvattha’s lead compound doesn’t neatly fit the definition of either one.”